NCT04079140View on ClinicalTrials.gov

Vaginal Dinoprostone Administration Prior to Intrauterine Device Insertion

PHASE4CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

September 15, 2019

Primary Completion Date

November 30, 2019

Study Completion Date

December 10, 2019

Conditions
IUD Insertion Pain
Interventions
DRUG

Dinoprostone

1 vaginal tablet of dinoprostone (3mg) (prostin® E2, Pharmacia \& Upjohn, Puurs, Belgium) self-inserted by the patient 12 hours before IUD insertion.

DRUG

placebo

one tablet of placebo self-inserted by the patient 12 hours before IUD insertion.

Trial Locations (1)

11231

faculty of medicine Cairo university, Giza

All Listed Sponsors
lead

Cairo University

OTHER

NCT04079140 - Vaginal Dinoprostone Administration Prior to Intrauterine Device Insertion | Biotech Hunter | Biotech Hunter